Third-Line Hormonal Treatment with Exemestane in Postmenopausal Patients with Advanced Breast Cancer Progressing on Letrozole or Anastrozole. A Phase II Trial Conducted by the Hellenic Group of Oncology (HELGO)-Reference-Cited by-同舟云学术

Third-Line Hormonal Treatment with Exemestane in Postmenopausal Patients with Advanced Breast Cancer Progressing on Letrozole or Anastrozole. A Phase II Trial Conducted by the Hellenic Group of Oncology (HELGO)

Published:2006-01 Issue:1 Volume:92 Page:13-17
ISSN:0300-8916
Container-title:Tumori Journal
language:en
Short-container-title:Tumori Journal

Author:

Gennatas Constantine¹,Michalaki Vasiliki¹,Carvounis Eleni²,Psychogios John¹,Poulakaki Nikiforita¹,Katsiamis George¹,Voros Dionysios¹,Kouloulias Vasilis¹,Mouratidou Despina³,Tsavaris Nikolaos⁴

Affiliation:

1. Department of Surgery, Athens, Greece

2. Department of Pathology, Areteion Hospital, University of Athens, Athens, Greece

3. Theagenion Cancer Hospital, Thessaloniks, Athens, Greece

4. Department of Pathophysiology, Laiko Hospital, University of Athens, Athens, Greece

Publisher

SAGE Publications

Subject

Cancer Research,Oncology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/030089160609200103

Reference20 articles.